Prognostic Significance of Fatty Liver Disease in Bariatric Patients (PROMETHEUS)
Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark
Listed as NCT03535142, this NA trial focuses on Metabolic Encephalopathy and Non-Alcoholic Fatty Liver Disease and remains actively recruiting participants. Sponsored by Esbjerg Hospital - University Hospital of Southern Denmark, it has been updated 11 times since 2018, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
11 versions recorded-
Apr 2025 — Present [monthly]
Recruiting NA
-
Oct 2024 — Apr 2025 [monthly]
Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Recruiting NA
-
Apr 2022 — Oct 2023 [monthly]
Recruiting NA
-
Apr 2021 — Apr 2022 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Jan 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Esbjerg Hospital - University Hospital of Southern Denmark
- Esbjerg University Hospital of South-West Jutland
- Odense University Hospital
- University of Southern Denmark
For direct contact, visit the study record on ClinicalTrials.gov .